“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, bipolar illness, suicide, and addictions in youth users.

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

The proportion of new schizophrenia cases linked to cannabis use in Ontario, Canada, increased from 4% prior to legalization to 10% following. | Cannabis Sciences ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

“I think the concern is that daily cannabis use has really increased in the last 15 years and at the same time the potency of ...

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...

Cannabis use disorder requiring hospital-based care is linked to an increased risk for premature death in a new cohort study.

Cannabis is gaining widespread appeal and a growing number of U.S. states are approving medical marijuana. A large study ...

Two new studies led by Ottawa researcher Dr. Daniel Myran link higher rates of death as well as “concerning increases” in new schizophrenia diagnoses to cannabis use disorder. One study found ...

New schizophrenia cases linked to cannabis use disorder more than doubled in Ontario after legalisation of drug ...

The use of medically recommended cannabis by adults is associated with a higher prevalence of cannabis use disorder vs ...